HCW Biologics Inc. 8-K

What Happened HCW Biologics Inc. (HCWB) filed a Current Report on Form 8-K on March 31, 2026 (Item 2.02) to announce its financial results for the quarter ended December 31, 2025. The company furnished the full text of the press release announcing those quarterly results as Exhibit 99.1 to the 8-K. The filing is signed by Founder and Chief Executive Officer Hing C. Wong.

Key Details

• Filing date: March 31, 2026 (Form 8-K, Item 2.02 — Results of Operations and Financial Condition).
• Reporting period: quarter ended December 31, 2025.
• Press release: furnished as Exhibit 99.1 to the 8-K.
• Signature: report signed by Hing C. Wong, Founder and Chief Executive Officer.

Why It Matters The 8-K confirms HCW Biologics has publicly released its latest quarterly earnings and related financial information; investors should review the attached press release (Exhibit 99.1) for specifics on revenue, earnings, cash position, and operational updates. This filing is a standard disclosure that makes the company’s quarterly results official and available to the market.